Abiopharma

News list

Davis Blaine 🔴 sold 10.6K shares of Cartesian Therapeutics, Inc. (RNAC) at $6.82 Transaction Date: Jan 06, 2026 | Filing ID: 000045

Full text

News bot Jan. 8, 2026, 9:26 p.m.
🔍 Davis Blaine (Executive)

Company: Cartesian Therapeutics, Inc. (RNAC)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 10,591
Detailed Transactions and Holdings:
- Sold 10,591 shares of Common Stock at $6.8197 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 121,220.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.